Search Results - "Ong, A T L"

How to accelerate the endothelialization of stents by Ong, A T L, Aoki, J, Kutryk, M J, Serruys, P W

“…Coronary artery stenting is currently the most frequently performed percutaneous coronary intervention for the treatment of coronary artery disease. The…”
Get more information

Methodological considerations and approach to cross-technique comparisons using in vivo coronary plaque characterization based on intravascular ultrasound radiofrequency data analysis: insights from the Integrated Biomarker and Imaging Study (IBIS) by Rodriguez-Granillo, G A, Aoki, J, Ong, A T L, Valgimigli, M, Van Mieghem, C A G, Regar, E, McFadden, E, De Feyter, P, Serruys, P W

“…Grey scale intravascular ultrasound (IVUS) is a valuable clinical tool to assess the extent and severity of coronary atheroma. However, it cannot reliably…”
Get more information

One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents by Hofma, S H, Ong, A T L, Aoki, J, van Mieghem, C A G, Rodriguez Granillo, G A, Valgimigli, M, Regar, E, de Jaegere, P P T, McFadden, E P, Sianos, G, van der Giessen, W J, de Feyter, P J, Van Domburg, R T, Serruys, P W

“…Objective: To compare clinical outcome of paclitaxel eluting stents (PES) versus sirolimus eluting stents (SES) for the treatment of acute ST elevation…”
Get full text

Drug-eluting stents for all patients by Ong, A T L, van der Giessen, W J

Get full text

One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compare with sirolimus eluting stents by HOFMA, S. H, ONG, A. T. L, VAN DER GIESSEN, W. J, DE FEYTER, P. J, VAN DOMBURG, R. T, SERRUYS, P. W, AOKI, J, VAN MIEGHEM, C. A. G, GRANILLO, G. A, VALGIMIGLI, M, REGAR, E, DE JAEGERE, P. P. T, MCFADDEN, E. P, SIANOS, G

Get full text

Wake up call for Dutch cardiologists by Serruys, P W, Ong, A T L

“…Drug-eluting stents have been available in the Netherlands since April 2002. Despite the revolutionary randomised data demonstrating their low rate of…”
Get full text

Sirolimus-releasing coronary stent: lessons from the Rotterdam experience by Lemos, P A, Mc Fadden, E P, Ong, A T L, de Feyter, P J, Serruys, P W

Get full text

Stent coronaire à libération de sirolimus : les leçons de l'expérience de Rotterdam: La saga du sirolimus by LEMOS, P. A, MCFADDEN, E. P, ONG, A. T. L, DE FEYTER, P. J, SERRUYS, P. W

Get full text

New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis by Vaina, S, Ong, A T L, Serruys, P W

“…The development of drug-eluting stents is one of the major revolutions in the field of Interventional Cardiology. Restenosis rate has been significantly…”
Get more information

Five-Year Clinical Effect of Coronary Stenting and Coronary Artery Bypass Grafting in Renal Insufficient Patients With Multivessel Coronary Artery Disease: Insights From ARTS Trial by Aoki, J., Ong, A.T.L., Hoye, A.

Get full text

The Unrestricted Use of Paclitaxel- Versus Sirolimus-Eluting Stents for Coronary Artery Disease in an Unselected Population: One-Year Results of the Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registry by Ong, A.T.L., Serruys, P.W., Aokiet, J.

Get full text

Thirty-Day Incidence and Six-Month Clinical Outcome of Thrombotic Stent Occlusion After Bare-Metal, Sirolimus, or Paclitaxel Stent Implantation by Ong, A.T.L., Hoye, A., Aoki, J.

Get full text

Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease: The Final Analysis of the Arterial Revascularization Therapies Study (ARTS) Randomized Trial by Serruys, P.W., Ong, A.T.L., van Herwerden, L.A.

Get full text